Talk to us

Whitepaper

  • A comparative study reveals the pros and cons of 3 common approaches to cytokine release assessment.
  • Learn how to secure statistically relevant results to include in your investigational medicinal product dossier (IMPD), investigational new drug application (IND) or clinical trial application (CTA).
  • Get important insights on what aspects to consider when assessing the potential for cytokine release in humans.